Adverum Biotechnlgs (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADVM | BMY | AMGN | GILD | VRTX |
| Company | Adverum Biotechnlgs | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.6100 | 58.84 | 267.54 | 74.75 | 350.00 |
| High | 1.6500 | 59.28 | 267.80 | 74.93 | 350.80 |
| Low | 1.5700 | 58.55 | 265.01 | 74.53 | 344.62 |
| Last | 1.6000 | 59.16 | 266.86 | 74.83 | 350.67 |
| Change | -0.0800 | +0.26 | -0.84 | -0.18 | +1.14 |
| % Change | -4.76% | +0.44% | -0.31% | -0.24% | +0.33% |
| Volume | 184,300 | 7,005,900 | 1,705,200 | 3,885,700 | 698,100 |
| 20-Day Average Volume | 206,810 | 11,682,000 | 2,272,670 | 5,270,060 | 908,405 |
| Previous Close | 1.6800 | 58.90 | 267.70 | 75.01 | 349.53 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.6730 | 60.20 | 260.46 | 76.09 | 349.43 |
| 20-Day Raw Stochastic | 47.99% | 16.34% | 74.83% | 30.10% | 55.41% |
| 20-Day Relative Strength | 46.49% | 40.69% | 61.10% | 42.62% | 51.48% |
| Weighted Alpha | +66.60 | -19.60 | +18.80 | +9.70 | +20.20 |
| Today's Opinion | 40% Buy | 100% Sell | 88% Buy | 100% Sell | 80% Buy |
| Previous Opinion | 56% Buy | 100% Sell | 88% Buy | 100% Sell | 64% Buy |
| Last Month's Opinion | 56% Buy | 100% Sell | 72% Buy | 80% Sell | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.90% since 09/18/23 | +0.99% since 09/18/23 | +1.41% since 09/18/23 | -1.04% since 09/18/23 | -0.38% since 09/18/23 |
| Low | 1.3601 on 09/19/23 | 58.34 on 09/19/23 | 262.44 on 09/19/23 | 74.35 on 09/22/23 | 344.62 on 09/25/23 |
| High | 1.7000 on 09/22/23 | 59.46 on 09/21/23 | 273.08 on 09/20/23 | 76.39 on 09/20/23 | 358.59 on 09/20/23 |
| 1-Month | |||||
| %Chg | unch since 08/25/23 | -4.70% since 08/25/23 | +4.09% since 08/25/23 | -2.64% since 08/25/23 | +0.17% since 08/25/23 |
| Low | 1.3601 on 09/19/23 | 58.33 on 09/18/23 | 248.38 on 09/06/23 | 73.25 on 09/06/23 | 340.83 on 09/06/23 |
| High | 1.8600 on 08/30/23 | 63.41 on 08/29/23 | 273.08 on 09/20/23 | 78.50 on 08/30/23 | 358.59 on 09/20/23 |
| 3-Month | |||||
| %Chg | +20.30% since 06/23/23 | -9.04% since 06/23/23 | +17.50% since 06/23/23 | -3.41% since 06/23/23 | +1.06% since 06/23/23 |
| Low | 1.1900 on 06/26/23 | 58.33 on 09/18/23 | 218.44 on 07/07/23 | 73.25 on 09/06/23 | 335.82 on 07/07/23 |
| High | 2.3400 on 07/19/23 | 65.38 on 07/24/23 | 273.08 on 09/20/23 | 81.43 on 08/09/23 | 367.00 on 07/21/23 |
| 6-Month | |||||
| %Chg | +111.17% since 03/24/23 | -12.59% since 03/24/23 | +12.11% since 03/24/23 | -6.46% since 03/24/23 | +11.54% since 03/24/23 |
| Low | 0.6810 on 04/10/23 | 58.33 on 09/18/23 | 211.71 on 06/01/23 | 73.25 on 09/06/23 | 307.93 on 03/27/23 |
| High | 2.3400 on 07/19/23 | 71.07 on 04/06/23 | 273.08 on 09/20/23 | 87.37 on 04/24/23 | 367.00 on 07/21/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 169,668 | 123,048,168 | 143,192,992 | 93,463,520 | 90,211,952 |
| Shares Outstanding, K | 100,993 | 2,089,103 | 534,901 | 1,246,014 | 258,095 |
| Annual Sales | 0 | 46,159,000,000 | 26,323,000,000 | 27,281,000,000 | 8,930,700,000 |
| Annual Net Income | -154,540,000 | 6,327,000,000 | 6,552,000,000 | 4,592,000,000 | 3,322,000,000 |
| Last Quarter Sales | 3,600,000 | 11,226,000,000 | 6,986,000,000 | 6,599,000,000 | 2,493,200,000 |
| Last Quarter Net Income | -29,060,000 | 2,073,000,000 | 1,379,000,000 | 1,045,000,000 | 915,700,000 |
| 60-Month Beta | 0.82 | 0.42 | 0.61 | 0.37 | 0.51 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 08/10/23 | 1.75 on 07/27/23 | 5.00 on 08/03/23 | 1.34 on 08/03/23 | 3.89 on 08/01/23 |
| Latest Earnings Date | 11/09/23 | 10/26/23 | 11/02/23 | 10/26/23 | 10/26/23 |
| Most Recent Dividend | N/A | 0.570 on 07/06/23 | 2.130 on 08/17/23 | 0.750 on 09/14/23 | N/A |
| Next Ex-Dividends Date | N/A | 10/05/23 | 08/17/23 | 09/14/23 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 7.76 | 15.16 | 11.99 | 26.94 |
